EMAIL THIS PAGE TO A FRIEND

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics

Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?


PMID 18840236

Abstract

Race is not a scientific category, but African Americans have increased prevalence and severity of heart failure. The African American Heart Failure trial showed the benefit of a combination of isosorbide dinitrate (a nitric oxide donor) and hydralazine (an antioxidant). Future research may unmask the reason for cardiovascular differences in therapy.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

I0775000
Isosorbide dinitrate, European Pharmacopoeia (EP) Reference Standard
C6H8N2O8